Differences among western European countries in anticoagulation management of atrial fibrillation
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Differences among western European countries in anticoagulation management of atrial fibrillation
Authors
Keywords
-
Journal
THROMBOSIS AND HAEMOSTASIS
Volume 111, Issue 05, Pages 833-841
Publisher
Schattauer GmbH
Online
2014-03-20
DOI
10.1160/th13-12-1007
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Incidence, prevalence, and antithrombotic management of atrial fibrillation in elderly Germans
- (2013) Christoph Ohlmeier et al. EUROPACE
- European Heart Rhythm Association Practical Guide on the use of new oral anticoagulants in patients with non-valvular atrial fibrillation
- (2013) Hein Heidbuchel et al. EUROPACE
- Management of atrial fibrillation in seven European countries after the publication of the 2010 ESC Guidelines on atrial fibrillation: primary results of the PREvention oF thromboemolic events—European Registry in Atrial Fibrillation (PREFER in AF)
- (2013) Paulus Kirchhof et al. EUROPACE
- A prospective survey in European Society of Cardiology member countries of atrial fibrillation management: baseline results of EURObservational Research Programme Atrial Fibrillation (EORP-AF) Pilot General Registry
- (2013) Gregory Y.H. Lip et al. EUROPACE
- Risk Profiles and Antithrombotic Treatment of Patients Newly Diagnosed with Atrial Fibrillation at Risk of Stroke: Perspectives from the International, Observational, Prospective GARFIELD Registry
- (2013) Ajay K. Kakkar et al. PLoS One
- Risk of Stroke or Systemic Embolism in Atrial Fibrillation Patients Treated With Warfarin
- (2013) Ida Ehlers Albertsen et al. STROKE
- Anticoagulation in patients with atrial fibrillation undergoing coronary stent implantation
- (2013) Anne Bernard et al. THROMBOSIS AND HAEMOSTASIS
- Cessation of oral anticoagulation in relation to mortality and the risk of thrombotic events in patients with atrial fibrillation
- (2013) Pilar Gallego et al. THROMBOSIS AND HAEMOSTASIS
- Vitamin K antagonists in heart disease: Current status and perspectives (Section III)
- (2013) Raffaele Caterina et al. THROMBOSIS AND HAEMOSTASIS
- Nonadherence with INR Monitoring and Anticoagulant Complications
- (2013) Daniel M. Witt et al. THROMBOSIS RESEARCH
- Perioperative Management of Antithrombotic Therapy
- (2012) James D. Douketis et al. CHEST
- Periprocedural Heparin Bridging in Patients Receiving Vitamin K Antagonists
- (2012) Deborah Siegal et al. CIRCULATION
- Variation in Warfarin Dose Adjustment Practice Is Responsible for Differences in the Quality of Anticoagulation Control Between Centers and Countries
- (2012) Harriette G.C. Van Spall et al. CIRCULATION
- Heart Disease and Stroke Statistics—2013 Update
- (2012) Alan S. Go et al. CIRCULATION
- 2012 focused update of the ESC Guidelines for the management of atrial fibrillation
- (2012) et al. EUROPEAN HEART JOURNAL
- Changes in the Prevalence, Treatment and Control of Hypertension in Germany? A Clinical-Epidemiological Study of 50.000 Primary Care Patients
- (2012) Alexander Michael Labeit et al. PLoS One
- Oral anticoagulation use by patients with atrial fibrillation in Germany
- (2012) Antje Groth et al. THROMBOSIS AND HAEMOSTASIS
- External quality assessment of point-of-care International Normalized Ratio (INR) testing in Europe
- (2011) Anne Stavelin et al. CLINICAL CHEMISTRY AND LABORATORY MEDICINE
- Management of atrial fibrillation by primary care physicians in Germany: baseline results of the ATRIUM registry
- (2011) Thomas Meinertz et al. Clinical Research in Cardiology
- Presentation of atrial fibrillation and its management by cardiologists in the ambulatory and hospital setting: MOVE cross-sectional study
- (2011) Hendrik Bonnemeier et al. CURRENT MEDICAL RESEARCH AND OPINION
- Impact of the type of centre on management of AF patients: Surprising evidence for differences in antithrombotic therapy decisions
- (2011) Andrea Gerth et al. THROMBOSIS AND HAEMOSTASIS
- Quality of individual INR control and the risk of stroke and bleeding events in atrial fibrillation patients: A nested case control analysis of the ACTIVE W study
- (2011) Robby Nieuwlaat et al. THROMBOSIS RESEARCH
- Variability of INR and its relationship with mortality, stroke, bleeding and hospitalisations in patients with atrial fibrillation
- (2011) Marcus Lind et al. THROMBOSIS RESEARCH
- A Novel User-Friendly Score (HAS-BLED) To Assess 1-Year Risk of Major Bleeding in Patients With Atrial Fibrillation
- (2010) Ron Pisters et al. CHEST
- Guidelines for the management of atrial fibrillation: The Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC)
- (2010) et al. EUROPEAN HEART JOURNAL
- Comparative Validation of a Novel Risk Score for Predicting Bleeding Risk in Anticoagulated Patients With Atrial Fibrillation
- (2010) Gregory Y.H. Lip et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Efficacy and safety of dabigatran compared with warfarin at different levels of international normalised ratio control for stroke prevention in atrial fibrillation: an analysis of the RE-LY trial
- (2010) Lars Wallentin et al. LANCET
- Assessing agreement between point of care and pathology laboratory results for INR: experiences from the Point of Care Testing in General Practice Trial
- (2010) Lisa N. Yelland et al. PATHOLOGY
- The RecordAF Study: Design, Baseline Data, and Profile of Patients According to Chosen Treatment Strategy for Atrial Fibrillation
- (2009) Jean-Yves Le Heuzey et al. AMERICAN JOURNAL OF CARDIOLOGY
- The Registry of the German Competence NETwork on Atrial Fibrillation: patient characteristics and initial management
- (2009) M. Nabauer et al. EUROPACE
- Effect of Age on Stroke Prevention Therapy in Patients With Atrial Fibrillation
- (2009) Carl van Walraven et al. STROKE
- Current Status of Stroke Risk Stratification in Patients With Atrial Fibrillation
- (2009) Robert G. Hart et al. STROKE
- Management of Antithrombotic Therapy in Atrial Fibrillation Patients Presenting with Acute Coronary Syndrome and/or Undergoing Percutaneous Coronary Intervention/ Stenting
- (2009) G. Y. H. Lip et al. THROMBOSIS AND HAEMOSTASIS
- Benefit of Oral Anticoagulant Over Antiplatelet Therapy in Atrial Fibrillation Depends on the Quality of International Normalized Ratio Control Achieved by Centers and Countries as Measured by Time in Therapeutic Range
- (2008) Stuart J. Connolly et al. CIRCULATION
- Warfarin treatment in patients with atrial fibrillation: Observing outcomes associated with varying levels of INR control
- (2008) Christopher Ll. Morgan et al. THROMBOSIS RESEARCH
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started